Buy zone, page-38

I took some risk with this company and traded a few times. I am currently holding some shares at 3.1c. Honestly, I don't like their management. They are highly overpaid, paid more than most of ASX200 and also cleverly cover dilution with 100s millions of underserved performance shares. My other concern is that they won't be transparent with actual sales and profit margin. Basically, they are not affected by the lower share price. Just hope profit doesn't go to someone pocket. People lost trust in Chinese based companies listed in ASX, Is it same for jew company? I will give one more quarter benefit of the doubt and want to see progress with the latest global expansion, and growth in revenue and prescription. I am aware of low cash and depend on London stock exchange listing. If it gets delayed, then CR is imminent.